Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Chris Viehbacher
Biotech
Braveheart, with Biogen CEO on board, rallies $185M series A
The biotech is led by former HI-Bio founder and CEO Travis Murdoch, M.D., while Biogen's CEO Chris Viehbacher chairs the board of directors.
Zoey Becker
Nov 5, 2025 7:51am
Biogen taps Royalty for $250M to fund phase 3 lupus program
Feb 12, 2025 8:10am
Biogen inks $1.15B HI-Bio buyout to expand in immunology
May 22, 2024 8:24am
To be better at neuroscience, Biogen will invest elsewhere
Apr 24, 2024 10:37am
New Biogen research chief aims to add biotech hustle to pharma
Oct 10, 2023 10:50am
Biogen's tight-lipped zuranolone remarks disquiet Sage investors
Jul 26, 2023 10:45am